 Pulmonary Fibrosis
"Pulmonary Fibrosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.
| Descriptor ID |
D011658
|
| MeSH Number(s) |
C08.381.765
|
| Concept/Terms |
Pulmonary Fibrosis- Pulmonary Fibrosis
- Pulmonary Fibroses
- Fibroses, Pulmonary
- Fibrosis, Pulmonary
Alveolitis, Fibrosing- Alveolitis, Fibrosing
- Alveolitides, Fibrosing
- Fibrosing Alveolitides
- Fibrosing Alveolitis
- Hamman-Rich Syndrome
- Hamman Rich Syndrome
- Syndrome, Hamman-Rich
|
Below are MeSH descriptors whose meaning is more general than "Pulmonary Fibrosis".
Below are MeSH descriptors whose meaning is more specific than "Pulmonary Fibrosis".
This graph shows the total number of publications written about "Pulmonary Fibrosis" by people in this website by year, and whether "Pulmonary Fibrosis" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 4 | 0 | 4 | | 1992 | 2 | 2 | 4 | | 1993 | 5 | 2 | 7 | | 1994 | 2 | 1 | 3 | | 1996 | 1 | 0 | 1 | | 1997 | 2 | 0 | 2 | | 1998 | 0 | 1 | 1 | | 2000 | 1 | 0 | 1 | | 2001 | 2 | 1 | 3 | | 2002 | 9 | 1 | 10 | | 2003 | 5 | 0 | 5 | | 2004 | 7 | 1 | 8 | | 2005 | 8 | 1 | 9 | | 2006 | 2 | 2 | 4 | | 2007 | 12 | 3 | 15 | | 2008 | 8 | 1 | 9 | | 2009 | 7 | 0 | 7 | | 2010 | 4 | 2 | 6 | | 2011 | 10 | 1 | 11 | | 2012 | 7 | 1 | 8 | | 2013 | 2 | 3 | 5 | | 2014 | 7 | 1 | 8 | | 2015 | 3 | 0 | 3 | | 2016 | 4 | 5 | 9 | | 2017 | 10 | 1 | 11 | | 2018 | 5 | 1 | 6 | | 2019 | 6 | 3 | 9 | | 2020 | 3 | 1 | 4 | | 2021 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Pulmonary Fibrosis" by people in Profiles.
-
Redente EF. How Do We Know What We Are Missing? Loss of Signaling through CD148 Drives Fibroblast Activation in Pulmonary Fibrosis. Am J Respir Crit Care Med. 2021 08 01; 204(3):249-251.
-
Guzy R, Redente EF. Kindlin for the Fire: Targeting Proline Synthesis to Extinguish Matrix Production in Pulmonary Fibrosis. Am J Respir Cell Mol Biol. 2021 07; 65(1):4-5.
-
Tomer Y, Wambach J, Knudsen L, Zhao M, Rodriguez LR, Murthy A, White FV, Venosa A, Katzen J, Ochs M, Hamvas A, Beers MF, Mulugeta S. The common ABCA3E292V variant disrupts AT2 cell quality control and increases susceptibility to lung injury and aberrant remodeling. Am J Physiol Lung Cell Mol Physiol. 2021 08 01; 321(2):L291-L307.
-
Mathai SK, Cardwell J, Metzger F, Powers J, Walts AD, Kropski JA, Eickelberg O, Hauck SM, Yang IV, Schwartz DA. Preclinical Pulmonary Fibrosis Circulating Protein Biomarkers. Am J Respir Crit Care Med. 2020 12 15; 202(12):1720-1724.
-
Raghu G, Remy-Jardin M, Ryerson CJ, Myers JL, Kreuter M, Vasakova M, Bargagli E, Chung JH, Collins BF, Bendstrup E, Chami HA, Chua AT, Corte TJ, Dalphin JC, Danoff SK, Diaz-Mendoza J, Duggal A, Egashira R, Ewing T, Gulati M, Inoue Y, Jenkins AR, Johannson KA, Johkoh T, Tamae-Kakazu M, Kitaichi M, Knight SL, Koschel D, Lederer DJ, Mageto Y, Maier LA, Matiz C, Morell F, Nicholson AG, Patolia S, Pereira CA, Renzoni EA, Salisbury ML, Selman M, Walsh SLF, Wuyts WA, Wilson KC. Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2020 08 01; 202(3):e36-e69.
-
Fernández Pérez ER, Koelsch TL, Leone PM, Groshong SD, Lynch DA, Brown KK. Clinical Decision-Making in Hypersensitivity Pneumonitis: Diagnosis and Management. Semin Respir Crit Care Med. 2020 04; 41(2):214-228.
-
Walsh SLF, Humphries SM, Wells AU, Brown KK. Imaging research in fibrotic lung disease; applying deep learning to unsolved problems. Lancet Respir Med. 2020 11; 8(11):1144-1153.
-
Flaherty KR, Wells AU, Brown KK. Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. Reply. N Engl J Med. 2020 02 20; 382(8):781.
-
Redente EF. ABC Transporters: An Overlooked Mechanism of Drug Failure in Our Preclinical Models? Am J Respir Cell Mol Biol. 2020 02; 62(2):130-131.
-
Rangarajan S, Thannickal VJ. Remember Me? The Bone Marrow in Pulmonary Fibrosis. Am J Respir Crit Care Med. 2019 10 15; 200(8):959-960.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|